We enrolled individuals aged 20-80 years who had metastatic colorectal cancer , had an Eastern Cooperative Oncology Group performance status of 0 or 1 , had assessable lesions , had received no previous chemotherapy or radiotherapy , could take drugs orally , and had adequate organ function .